May 17, 2024, 07:46 AM by

May 16, 2024, 08:08 AM by

Mural Health Named “Most Innovative Start-up” at the 2024 Citeline Awards

May 16, 2024, 08:08 AM by

IDT and Molecular Health have entered into a global multi-year agreement, starting in the U.S., to integrate their NGS capabilities.

May 16, 2024, 08:08 AM by

Icosagen announces a strategic partnership on selected projects with Lead Discovery Center GmbH (LDC) to discover novel monoclonal antibodies.

May 16, 2024, 08:08 AM by

Inceptua Group announces an expansion of an Early Access Program for cefiderocol for eligible patients in Argentina, Chile, Colombia, Guatemala, Mexico, and Panama.

May 16, 2024, 08:08 AM by

Vector Laboratories joins forces with Absolute Biotech, bolstering its role as a key manufacturer for life science customers, enriching its antibody reagents portfolio, and expanding its commercial presence into the UK and EU.

May 16, 2024, 05:00 AM by User Not Found

Bio-IT World | The lab of W. Andy Tao, professor of biochemistry at Purdue University, is pioneering a way to assess drug response based on metabolizing proteins found in circulating extracellular vesicles (EVs), which could serve as a surrogate of their expression level in the liver and become therapeutic targets for some cancers.

May 15, 2024, 08:31 AM by

Indica Labs announced today that it received FDA clearance for HALO AP Dx, an enterprise digital pathology platform, for primary diagnosis.

May 15, 2024, 08:31 AM by

Metrodora Institute and PrecisionLife announce the start of recruitment on a cohort of up to 1,000 patients into clinical trials to evaluate new diagnosis and treatment options for ME/CFS, Long Covid, and related disorders.

May 15, 2024, 08:31 AM by

May 15, 2024, 08:31 AM by

Elegen is leveraging their next-generation DNA synthesis and production technology to expand into clinical DNA scaleup and manufacturing, a move supported by this Series B round with new investors Trianomic Capital, GSK, and Aldevron co-founder John Ballantyne as well as existing investors. This expansion into clinical applications comes just a little over a year after launching their first product, ENFINIA DNA. To date the company has rapidly enhanced its platform to speed the upstream discovery phase of genetic medicine development, and in January announced a collaboration and licensing agreement with GSK. Investors are confident that Elegen's cell-free, turnkey synthetic DNA platform will transform the speed and reliability of clinical GMP DNA manufacturing.

May 15, 2024, 08:31 AM by

Kalderos Names Healthcare Industry Veteran Daryl Todd as Chief Strategy Officer

May 15, 2024, 08:31 AM by

InsightRX Continues Momentum in Precision Dosing with Client Growth, New Scientific Breakthroughs

May 15, 2024, 08:31 AM by

PLUTO’s embeddings will enable prediction of underlying molecular alterations driving cancer and disease phenotypes–including those previously hidden to AI–as well as the discovery of new biomarkers and therapeutic targets.

May 15, 2024, 08:31 AM by

May 15, 2024, 08:31 AM by

Optibrium’s AI-powered discovery platform Cerella™ chosen by FMC to accelerate its agrochemical discovery pipeline

May 15, 2024, 05:00 AM by User Not Found

Bio-IT World | Significant evidence now exists implicating the Epstein-Barr virus (EBV) as a causal factor in the development of multiple sclerosis (MS), making treatment of the virus a priority. To that end, research scientists at Trinity College Dublin have developed a blood test to measure the immune response to EBV that could be used as an outcome measure in future clinical trials in people with established MS.

May 14, 2024, 07:27 AM by

https://www.prnewswire.com/news-releases/fdb-expands-its-medication-instructions-to-include-translations-of-hindi--punjabi-2-of-the-fastest-growing-languages-in-the-us-302141989.html?tc=eml_cleartime

May 14, 2024, 07:27 AM by

Switchboard Health, creator of a high-value specialty care network and software platform, has secured $6.5 million in series seed funding.

May 14, 2024, 07:27 AM by